SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : One Big Scam? CTRN, ECTS, IVHD, SMEK & MALB

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pluvia who started this subject8/5/2003 12:10:42 PM
From: StockDung   of 559
 
SECURITIES AND EXCHANGE COMMISSION v. QUINTEK TECHNOLOGIES, INC., PANAMED CORP., AND THOMAS W. SIMS, CV-03-5513-RJICFMOx

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
LITIGATION RELEASE NO. 18268 / August 4, 2003
SECURITIES AND EXCHANGE COMMISSION v. QUINTEK TECHNOLOGIES, INC., PANAMED CORP., AND THOMAS W. SIMS, CV-03-5513-RJICFMOx

On August 1, 2003, the Securities and Exchange Commission filed a complaint in U.S. District Court for the Central District of California against Quintek Technologies, Inc. ("Quintek"), Thomas W. Sims ("Sims"), and PanaMed Corp. ("PanaMed"). The Commission's complaint alleges that between October 2001 and March 2002, Sims, who was then the president of both companies, wrote or reviewed five press releases issued by Quintek or PanaMed as well as memoranda and other materials disseminated to investors in a private offering of PanaMed stock. The complaint further alleges that the releases and offering materials contained false and misleading statements concerning, among other things, a large order for Quintek's product, testing of PanaMed's product, and revenue projections for PanaMed. Moreover, the complaint alleges that both companies failed to timely file numerous mandatory periodic reports with the Commission and that PanaMed has failed to file its most recent annual report.

The complaint seeks to permanently enjoin all of the defendants from further violations of Sections 10(b) and 13(a) of the Securities Exchange Act of 1934 ("Exchange Act") and Rules 10b-5, 13a-1 and 13a-13 thereunder, and, additionally, to permanently enjoin Sims and PanaMed from further violations of Section 17(a) of the Securities Act of 1933 ("Securities Act").

Quintek, without admitting or denying the allegations in the Commission's complaint, has consented to an order of permanent injunction against future violations of Sections 10(b) and 13(a) of the Exchange Act and Rules 10b-5, 13a-1 and 13a-13 thereunder. Sims, without admitting or denying the allegations in the Commission's complaint, has consented to an order permanently enjoining him from future violations of the foregoing provisions, as well as Section 17(a) of the Securities Act. Sims has also consented to an order imposing a five-year officer and director bar, a five-year penny stock bar, and a $25,000 civil money penalty.

SEC Complaint in this matter



sec.gov

--------------------------------------------------------------------------------
Home | Previous Page Modified: 08/04/2003
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext